Reintroducing antituberculosis therapy after Stevens-Johnson syndrome in human immunodeficiency virus-infected patients with tuberculosis: Role of desensitization

International Journal of Dermatology

Volumn 40, Issue 7, 2001, Pages 481-484

  Kura, Mahendra M ^a   Hira, Subhash K ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; DEXAMETHASONE; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STEROID; STREPTOMYCIN; THIOACETAZONE; TUBERCULOSTATIC AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; DESENSITIZATION; DOSE CALCULATION; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MALE; PROSPECTIVE STUDY; SKIN INJURY; STEVENS JOHNSON SYNDROME; TREATMENT FAILURE; TUBERCULOSIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTITUBERCULAR AGENTS; DESENSITIZATION, IMMUNOLOGIC; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHAMBUTOL; FEMALE; HUMANS; ISONIAZID; MALE; PYRAZINAMIDE; RIFAMPIN; STEVENS-JOHNSON SYNDROME; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 0034756302     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.2001.01173-7.x     Document Type: Letter

References (22)

1. Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with the acquired immunodeficiency syndrome in Germany
2. Adverse reactions to trimethoprim-sulfamethoxazole among children with human immunodeficiency virus infection
3. Spontaneous reports of drug induced erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in Denmark 1968-1991
4. Cotrimoxazole induced adverse cutaneous reaction during treatment of AIDS associated pneumocystosis
5. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis
6. Trimethoprim desensitization
7. Successful desensitization of two patients who previously developed Stevens-Johnson syndrome while receiving trimethoprimsulfamethoxazole
8. Cotrimoxazole desensitization in HIV seropositive patients
9. Cutaneous hypersensitivity reactions due to thiacetazone in the treatment of tuberculosis in Zambian children infected with HIV-I
10. HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone free antituberculosis treatment in Yaounde, Cameroon
11. Stevens-Johnson syndrome during antituberculosis chemotherapy in HIV seropositive patients: Report of six cases
12. Cycloserine induced Stevens-Johnson syndrome in an AIDS patient with multidrug resistant tuberculosis
13. Ciprofloxacin induced toxic epidermal necrolysis: A case report
14. Cutaneous manifestations of human immunodeficiency virus in Lusaka, Zambia
15. Human immunodeficiency virus type-1 infection in Zambian children with tuberculosis: Changing seroprevalence and evaluation of a thiacetazone free regimen
16. Risk factors for adverse drug reactions during thiacetazone treatment of pulmonary tuberculosis in human immunodeficiency virus infected adults
17. Developing an appropriate HIV classification for Asia and the Pacific
18. Tuberculosis in patients with HIV infection
19. Increased recurrence of tuberculosis in HIV-1 infected persons in Kenya
20. Cohort study of human immunodeficiency virus infection in patients with tuberculosis in Nairobi, Kenya: Analysis of early (6-month) mortality
21. HIV-associated tuberculosis in developing countries: Clinical features, diagnosis and treatment
22. Clinical profile of AIDS in India: A review of 61 cases